Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Trial of Belzutifan (PT2977, MK-6482) Tablets In Patients With Advanced Solid Tumors (MK-6482-001)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02974738
Recruitment Status : Active, not recruiting
First Posted : November 28, 2016
Last Update Posted : February 26, 2021
Sponsor:
Information provided by (Responsible Party):
Peloton Therapeutics, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : April 14, 2023
Estimated Study Completion Date : April 14, 2023